Preclinical efficacy of the HSP90 inhibitor SNX-5422 in targeting C481S mutant BTK and ibrutinib resistant CLLTimothy L. Chen,Bonnie Harrington,Jean Truxall,Ronni Wasmuth,Amy Lehman,Eric Orlemans,John C. Byrd,Jennifer A. Woyach,Erin HertleinCancer Research(2018)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要